These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 3988396

  • 1. Elimination kinetic of high polar metabolites pool of quinidine from human serum.
    Camsonne R, Moulin MA, Charbonneau P, Bazin C.
    Int J Clin Pharmacol Ther Toxicol; 1985 Feb; 23(2):74-5. PubMed ID: 3988396
    [Abstract] [Full Text] [Related]

  • 2. Dose-dependent kinetics of quinidine in the perfused rat liver preparation. Kinetics of formation of active metabolites.
    Yu VC, de Lamirande E, Horning MG, Pang KS.
    Drug Metab Dispos; 1982 Feb; 10(6):568-72. PubMed ID: 6130901
    [Abstract] [Full Text] [Related]

  • 3. [Elimination half-life of 3-hydroxyquinidine in man].
    Camsonne R, Moulin MA, Bazin C, Charbonneau P, Drieu L, Pedailles S, Briand A.
    Therapie; 1983 Feb; 38(1):115-6. PubMed ID: 6867995
    [No Abstract] [Full Text] [Related]

  • 4. Specific determination of quinidine and (3S)-3-hydroxyquinidine in human serum by high-pressure liquid chromatography.
    Drayer DE, Restivo K, Reidenberg MM.
    J Lab Clin Med; 1977 Nov; 90(5):816-22. PubMed ID: 908870
    [Abstract] [Full Text] [Related]

  • 5. Fetal supraventricular tachycardia treated with high-dose quinidine: toxicity associated with marked elevation of the metabolite, 3(S)-3-hydroxyquinidine.
    Killeen AA, Bowers LD.
    Obstet Gynecol; 1987 Sep; 70(3 Pt 2):445-9. PubMed ID: 3627599
    [Abstract] [Full Text] [Related]

  • 6. Disposition kinetics of dihydroquinidine following quinidine administration.
    Ueda CT, Williamson BJ, Dzindzio BS.
    Res Commun Chem Pathol Pharmacol; 1976 Jun; 14(2):215-25. PubMed ID: 940955
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Lack of effect of smoking on the metabolism and pharmacokinetics of quinidine in patients.
    Edwards DJ, Axelson JE, Visco JP, vanEvery S, Slaughter RL, Lalka D.
    Br J Clin Pharmacol; 1987 Mar; 23(3):351-4. PubMed ID: 3567051
    [Abstract] [Full Text] [Related]

  • 11. Quinidine-digoxin interaction: are the pharmacokinetics of both drugs altered?
    Rameis H.
    Int J Clin Pharmacol Ther Toxicol; 1985 Mar; 23(3):145-53. PubMed ID: 3997300
    [Abstract] [Full Text] [Related]

  • 12. [Relative bioavailability and influence of a quinidine retard-formulation on blood-pressure and ECG in healthy volunteers (author's transl)].
    Knapp W, Lechleitner P.
    Arzneimittelforschung; 1981 Mar; 31(9):1482-6. PubMed ID: 7197960
    [Abstract] [Full Text] [Related]

  • 13. Greater quinidine-induced QTc interval prolongation in women.
    Benton RE, Sale M, Flockhart DA, Woosley RL.
    Clin Pharmacol Ther; 2000 Apr; 67(4):413-8. PubMed ID: 10801251
    [Abstract] [Full Text] [Related]

  • 14. The effect of coadministration of verapamil on the pharmacokinetics and metabolism of quinidine.
    Edwards DJ, Lavoie R, Beckman H, Blevins R, Rubenfire M.
    Clin Pharmacol Ther; 1987 Jan; 41(1):68-73. PubMed ID: 3802708
    [Abstract] [Full Text] [Related]

  • 15. The bioavailability and kinetics of dihydroquinidine in patients with heart disease.
    Regazzi Bonora M, Salerno JA, Rondanelli R, Cristiani D, Chimienti M.
    Int J Clin Pharmacol Ther Toxicol; 1982 May; 20(5):212-8. PubMed ID: 7095920
    [Abstract] [Full Text] [Related]

  • 16. Rapid elimination of quinidine in pediatric patients.
    Szefler SJ, Pieroni DR, Gingell RL, Shen DD.
    Pediatrics; 1982 Sep; 70(3):370-5. PubMed ID: 7110810
    [Abstract] [Full Text] [Related]

  • 17. Assessment of quinidine gluconate for nonlinear kinetics following chronic dosing.
    Russo J, Russo ME, Smith RA, Pershing LK.
    J Clin Pharmacol; 1982 Sep; 22(5-6):264-70. PubMed ID: 7107973
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Diurnal oscillations in the serum and salivary levels of quinidine.
    Rao BR, Rambhau D.
    Arzneimittelforschung; 1995 Jun; 45(6):681-3. PubMed ID: 7646570
    [Abstract] [Full Text] [Related]

  • 20. Accumulation of 3-hydroxyquinidine following chronic quinidine therapy.
    Ackerman BH, Olsen KM, Pappas AA.
    DICP; 1991 Jun; 25(7-8):867-9. PubMed ID: 1949948
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.